[JANX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -55.05%
YoY- -32.81%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 1,252 2,048 1,589 380 0 -
PBT -14,760 -17,459 -13,410 -2,284 -1,413 79.70%
Tax 489 -453 -264 0 -393 -
NP -14,760 -17,459 -13,146 -2,284 -1,413 79.70%
Tax Rate - - - - - -
Total Cost 16,012 19,507 14,735 2,664 1,413 83.39%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin -1,178.91 -852.49 -827.31 -601.05 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.30 -0.42 -0.32 -0.06 -0.11 28.48%
EPS Diluted -0.30 -0.42 -0.32 -0.06 -0.11 28.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.